Hepatocyte Growth Factor Attenuates Transforming Growth Factor--Angiotensin II Crosstalk Through Inhibition of the PTEN/Akt Pathway

Abstract

Abstract—Both angiotensin II (Ang II) and transforming growth factor (TGF)-1 are thought to be involved in the progression of chronic kidney disease. In contrast, hepatocyte growth factor (HGF) counteracts the actions of Ang II and TGF-1. Therefore, in this study, we investigated the molecular mechanisms of how HGF antagonizes the Ang II-TGF- axis in renal cells. In cultured human mesangial cells, TGF-1 increased angiotensin type 1 receptor (AT1R) mRNA, mainly dependent on the Akt/phosphatidylinositol 3-kinase signaling pathway. Furthermore, TGF-1 decreased the expression and phosphatase activity of phosphatase and tensin homolog, deleted on chromosome 10 (PTEN), a negative regulator of the phosphatidylinositol 3-kinase/Akt pathway. These data revealed positive feedback of the Ang II-TGF- pathway, because Ang II increased TGF- expression. In contrast, HGF significantly attenuated the increase in AT1R gene expression, and inhibited the decrease in PTEN induced by TGF-1. Of importance, a PTEN-specific inhibitor significantly attenuated the reduction in TGF-1–induced AT1R expression by HGF. These data suggest that HGF attenuated TGF-1–induced AT1R expression through the PTEN/Akt pathway. To investigate this hypothesis, we performed in vivo experiments in mice with increased circulating levels of HGF produced by transgenically expressing HGF under control of a cardiac-specific transgene (HGF-Tg). In HGF-Tg mice, renal injury and fibrosis were significantly decreased, associated with reduction in AT1R expression and increase in PTEN after Ang II infusion, as compared with control mice. Moreover, these renal protective effects were abrogated by a neutralizing antibod